NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Neuralace Medical

Neuralace Medical

Private
San Marcos, CaliforniaHealthcare & Life Scienceshttps://neuralacemedical.com/

Last Round

Seed

May 30, 2023

Total Funding Raised

$5.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neuralace Medical is a medical device company that develops non-invasive neuromodulation technology for the treatment of chronic neuropathic pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

neuromodulationmagnetic peripheral nerve stimulationmPNSchronic pain managementneuropathic painnon-invasive medical devicepain relief technologydiabetic neuropathy treatmentdrug-free pain reliefpain management clinicmedical device salesnerve stimulationpain technon-opioid pain treatmentB2G

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuralace Medical Comps

Public and private peers based on sector, stage, and business model.

Neuralace Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neuralace Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 30, 2023
SeedJun 19, 2019
GrantOct 24, 2018
SeedMar 15, 2017

Neuralace Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 31% MoM.

  • Apr 18, 2026

    Grew 29% QoQ from 17 to 22 employees.

Neuralace Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuralace Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuralace Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Marcos, California
Employee Range22
Year Founded2011
Last FundingMay 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.